News and Announcements
Want to be the first to hear about NU GoKidney updates, events, & resources? Join our mailing list.
NUGoKidney Pilot & Feasibility awardee, Anand Srivastava, MD, MPH, recently received a five-year K23 award from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK). The study aims to examine whether information about kidney blood flow obtained from contrast enhanced ultrasound (CEUS) will help identify patients with chronic kidney disease (CKD) who are at high risk of experiencing progressive loss of kidney function.
On April 29, 2020, NUGoKidney presented the webinar - CRRT for AKI during the COVID-19 Pandemic - with special guest, Ashita Tolwani, MD from the University of Alabama at Birmingham (UAB).
Dr. Tolwani explained how CRRT prescription might need to be adjusted in regards to modality, dose, and anticoagulation for AKI patients with COVID-19.
Click here to view a recording of the webinar.
Studied by Jing Jin, MD, PhD and his team as a therapy for acute kidney injury (AKI) and hypertension, ACE2-fc, was recently included in an article by Robert Kruse, MD, PhD in F100 Research as a potential therapy for COVID-19.
Dr. Jin talks with NM Better Edge podcast about how the ACE2-fc therapy could potentially be used to guard against and treat COVID-19 and highlights the important role of cross collaboration in facilitating discovery. Listen now here.
Over 70 high school juniors from Holy Trinity High School participated in the SciHigh workshop - Data IRL: Thinking Big & Improving Health - focused on real-world uses of data and computing in medicine and health research.
Last year on World Kidney Day, we reached nearly 400,000 people with our #sockittokidneydisease campaign, and we're doing it again this year to amplify the World Kidney Day 2020 message on the importance of preventive interventions to avert the onset and progression of kidney disease.
Ready your socks and learn how you can sock it to kidney disease.
2019 was an incredible year for advancing kidney health and NUGoKidney. Take a look back with us as we reflect on some of our favorite moments and achievements from the past year.
NUGoKidney Director, Susan Quaggin, was recently selected as one of Crain's Most Notable Women in Health Care. In its second year, the prestigious honor spotlights the impressive and influential women leaders that have made an impact for both patients and health care workers in Chicago's health care community.
Honorees included other exceptional leaders from the Feinberg School of Medicine including Connie Falcone, JD, MBA; Amy Paller, MD; Diane Wayne, MD; Anna Shannahan, MD; Michelle Stephenson, DNP, RN, NEA-BC; Teresa Woodruff, PhD; and Joanne C. Smith, MD.
ASN's Kidney Week 2019 is finally here! We have over 60 presentations, sessions, and posters showcasing research from NUGoKidney and Northwestern researchers.
On Friday, October, 18th, NUGoKidney held its first ever Kidney Disease Therapeutic Innovation Symposium entitled, The Revolution in Kidney Medicine: Creating a World Beyond Kidney Disease.
Over 100 attendees joined the day of expert-led presentations, lightning talks, poster competition, and networking session. The event provided NUGoKidney and the kidney research community with opportunities to build expertise and forge new collaborations for advancing therapeutic discovery and implementation in kidney diseases.
- 10.21.2019NUGoKidney's Director - Susan Quaggin, MD, - honored with election to the National Academy of Medicine. Read the full story here.
NUGoKidney will work with Endeleo Institute and Dinee Simpson, MD from Northwestern’s Comprehensive Transplant Center, on a 1-year project to develop community partnerships around improving health disparities related to kidney disease thanks to a partnership development grant from NUCATS Center for Community Health's Alliance for Research in Chicago Communities.
Read more about the project here.
Join NUGoKidney and Dr. Dinee Simpson on Saturday, October 5th for a community event to filter through common misconceptions, racial and ethnic disparities, and everything you need to know about keeping your kidneys healthy.
Click here to reserve your seat!
From building a hub for kidney research with NUGoKidney to finding new therapeutic targets, Susan Quaggin, MD - Director of NUGoKidney and Chief of the Division of Nephrology and Hypertension - shares what inspired her to become a physician and what continues to inspire her vision of a future without kidney disease.
We've extended the deadline to submit posters for our Kidney Therapeutics Innovation Symposium happening on Friday, Oct. 18.
- 08.26.2019As summer comes to a close, we take a look back at the incredible work of our first cohort of SciHigh summer students. Click here to read about the students' closing showcase of their research projects and their highlights from the summer.
NUGoKidney 2018 Pilot & Feasibility Awardee and Assistant Professor of Pharmacology - Paul DeCaen, PhD - publishes new article in the Proceedings of the National Academy of Sciences (PNAS) on the molecular mechanisms of ion channels and kidney disease.
Dr. DeCaen will be presenting an update on his funded project at our NUGoKidney Innovation Symposium on Friday, Oct. 18.
- 08.14.2019Final blog from our SciHigh Summer students. Chantel Beltran - rising senior at Holy Trinity High School - talks about her journey of self-discovery through learning about research.
SciHigh Summer Program participant and Holy Trinity High School junior, Monserrat Estrada, explores different areas of science and learns imperfections are opportunities to improve science.
Click here to read on about her SciHigh experience.
Gabriel Sheikh, SciHigh Summer student with Dr. Quaggin's lab, shares the projects he's working on, what he's learned, and his growing interest in biomedical engineering.
Read all about it here.
Director of NUGoKidney Therapeutic Design & Development Core (Core B), Jason Wertheim, MD, PhD, has been awarded the Presidential Early Career Award for Scientists and Engineers (PECASE). Wertheim received the honor for his innovative and applied research investigating how injured tissues and organs heal, regenerate, and repair to develop new tissues as future treatments for chronic organ failure.
Read more about Dr. Wertheim and his work here.
- 07.16.2019NUGoKidney SciHigh Summer Program participant, Aaron Jaszczor shares his experiences and how he's discovered his passion for medicine and research.
Northwestern University’s Center for Advanced Molecular Imaging (CAMI) is offering pilot project funding for up to TEN projects/year during each of the next three years to researchers with nascent imaging projects that will benefit from CAMI expertise in imaging method development and refinement.
Selected projects will be funded for a period of one year and up to $5,000 (and in very special circumstances, up to $7,500) direct costs for imaging studies performed in CAMI.
Proposal deadline extended: August 19, 2019
Read the full application guidelines here.
NUGoKidney and the Chemistry of Life Processes Institute have assembled some Feinberg School of Medicine's top experts onkidney disease for a workshop on July 31st covering the fundamentals of kidney disease and new areas of scientific discovery in this therapeutic area.
Students, trainees, and faculty new to kidney science encouraged to attend.
Click here to reserve your seat today!
- 06.11.2019This summer NUGoKidney will welcome 5 highly motivated students from Holy Trinity High School - a school located on Chicago’s West Side - to participate in its inaugural Sci-High program.
- 05.28.2019Tamara Isakova, MD - Director of NUGoKidney's Clinical & Translational Core (Core C) - selected to receive the American Society of Nephrology (ASN) 2019 Distinguished Mentor Award.
NU GoKidney Director, Susan Quaggin, and Therapeutics Design & Development Core Associate Director, Evan Scott joined esteemed NU GoKidney partners, Chemistry of Life Processes (CLP) Institute for their inaugural Biotech Summit by the Lake on March 27, 2019.
As part of the scientific showcase bringing together researchers, investors, and potential collaborators, Drs. Quaggin and Scott each presented their innovative research aimed at disease intervention.
Learn more about the Summit and CLP here.